Sir, We previously reported in this journal, the occurrence of thrombotic thrombocytopenic purpura in two sisters during their first pregnancy.' One of these patients had two subsequent pregnancies. Prophylactic low dose aspirin and periodic fresh frozen plasma infusion were administered starting in week 12 of the second pregnancy. This second pregnancy was uneventful with normal delivery of a healthy female baby. The patient also received prophylactic aspirin 100 mg daily without fresh frozen plasma infusion, during the third pregnancy. She did well until the 38th week of pregnancy when thrombotic thrombocytopenic purpura relapsed, manifesting as a mild purpuric rash, thrombocytopenia and microangiopathic haemolytic anaemia. Plasma exchange therapy resulted in a quick recovery. Labour was induced shortly after she recovered because pelvic ultrasound indicated possible growth retardation of the baby. She delivered a healthy male baby, although a blood count showed him to have erythrocytosis, indicating possible intrauterine hypoxia. The baby developed physiologic jaundice from which he recovered without complication.
This experience suggests the feasbility of pregnancy in patients with previous history of thrombotic thrombocytopenic purpura; prophylactic aspirin and plasma infusion appear to be beneficial in preventing relapse during pregnancy. 
